EUVIMEDSkopri EUVIMED
CrossrefKarta ta’ informazzjoni

Constitutive mTORC1 activation in skeletal muscle increases inflammation but is not sufficient to impair glucose tolerance

Erik D. Marchant, Hanna Kalenta, Sean P. Kilroe, Jacquelyn May, Wenjun Z. Martini, Korri S. Weldon, Zhao Lai, Blake B. Rasmussen

Function · 2026-08-01 · 7 (4)

DOI: 10.1152/function.039.2026 ↗
AstrattDettalji biblijografiċi

Astratt

Chronic skeletal muscle mTORC1 hyperactivation is widely assumed to drive insulin resistance and metabolic decline, yet direct causal evidence remains limited. Using adult-onset Depdc5 deletion to constitutively activate mTORC1 via GATOR1 disruption, we show that this is insufficient to impair glucose homeostasis even under a Western diet challenge. Strikingly, glucose tolerance and mitochondrial respiration remained preserved despite inflammation and immune transcriptional reprogramming—challenging the prevailing model of mTORC1-driven metabolic dysfunction in muscle.

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.

Ara t-tariffi →